Dr. Daniel Catenacci, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Area of expertise
Stomach Cancer
Daniel Catenacci, MD has run 10 trials for Stomach Cancer. Some of their research focus areas include:
Esophageal Cancer
Daniel Catenacci, MD has run 6 trials for Esophageal Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Chicago Comprehensive Cancer Center
University Of Chicago Medical Center
Clinical Trials Daniel Catenacci, MD is currently running
mFOLFIRINOX
for Stomach Cancer
This pilot clinical trial studies genetic analysis-guided irontecan hydrochloride dosing of modified fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin (mFOLFIRINOX) in treating patients with gastroesophageal or stomach cancer that has spread from where it started to nearby tissue or lymph nodes. Drugs used in chemotherapy, such as fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Leucovorin calcium may also help fluorouracil work better. Genetic analysis may help doctors determine what dose of irinotecan hydrochloride patients can tolerate.
Recruiting
3 awards
Phase 4
Chemotherapy Combination
for Cancer
The purpose of the proposed study is to establish the safety of combining irinotecan chemotherapy with 5-FU, leucovorin/folinic acid, oxaliplatin, and docetaxel (abbreviated as the I-FLOAT study of gFOLFOXIRITAX) chemotherapies (leucovorin/folinic acid is a vitamin to make 5-FU work well).
Recruiting
3 awards
Phase 1
More about Daniel Catenacci, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Daniel Catenacci, MD has experience with
- Trastuzumab
- Tucatinib
- Pembrolizumab
- Leucovorin
- Oxaliplatin
- Fluorouracil
Breakdown of trials Daniel Catenacci, MD has run
Stomach Cancer
Esophageal Cancer
Esophageal Adenocarcinoma
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Catenacci, MD specialize in?
Daniel Catenacci, MD focuses on Stomach Cancer and Esophageal Cancer. In particular, much of their work with Stomach Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Daniel Catenacci, MD currently recruiting for clinical trials?
Yes, Daniel Catenacci, MD is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Daniel Catenacci, MD has studied deeply?
Yes, Daniel Catenacci, MD has studied treatments such as Trastuzumab, Tucatinib, Pembrolizumab.
What is the best way to schedule an appointment with Daniel Catenacci, MD?
Apply for one of the trials that Daniel Catenacci, MD is conducting.
What is the office address of Daniel Catenacci, MD?
The office of Daniel Catenacci, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.